TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: 700nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: 1.70E+3nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: 2.50E+3nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: 3.00E+3nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: 4.30E+3nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: 4.50E+3nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: 4.80E+3nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: >5.60E+3nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: 5.90E+3nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: 6.00E+3nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: 1.05E+4nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: >1.10E+4nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: 1.13E+4nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: >1.20E+4nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: 1.50E+4nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: 1.90E+4nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: 2.80E+4nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: 4.10E+4nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: >4.40E+4nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: >4.40E+4nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: 4.80E+4nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: 5.80E+4nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: >8.90E+4nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: 9.40E+4nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: 1.36E+5nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: >1.78E+5nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Astrazeneca Discovery
Curated by ChEMBL
Astrazeneca Discovery
Curated by ChEMBL
Affinity DataKi: >1.78E+5nMAssay Description:Inhibition of human liver MAOA expressed in yeastMore data for this Ligand-Target Pair
Affinity DataIC50: 2nMAssay Description:Inhibition of Staphylococcus aureus DNA gyrase B expressed in Escherichia coli BL21(DE3) cells assessed ATP hydrolysis activity after 18 to 24 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 4nMAssay Description:Inhibition of Staphylococcus aureus DNA gyrase B expressed in Escherichia coli BL21(DE3) cells assessed ATP hydrolysis activity after 18 to 24 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 5nMAssay Description:Inhibition of Staphylococcus aureus DNA gyrase B expressed in Escherichia coli BL21(DE3) cells assessed ATP hydrolysis activity after 18 to 24 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 9nMAssay Description:Inhibition of Staphylococcus aureus DNA gyrase B expressed in Escherichia coli BL21(DE3) cells assessed ATP hydrolysis activity after 18 to 24 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 11nMAssay Description:Inhibition of Staphylococcus aureus DNA gyrase B expressed in Escherichia coli BL21(DE3) cells assessed ATP hydrolysis activity after 18 to 24 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 23nMAssay Description:Inhibition of Staphylococcus aureus DNA gyrase B expressed in Escherichia coli BL21(DE3) cells assessed ATP hydrolysis activity after 18 to 24 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 36nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 39nMAssay Description:Inhibition of Staphylococcus aureus DNA gyrase B expressed in Escherichia coli BL21(DE3) cells assessed ATP hydrolysis activity after 18 to 24 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: <40nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 42nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 57nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 58nMAssay Description:Inhibition of Staphylococcus aureus DNA gyrase B expressed in Escherichia coli BL21(DE3) cells assessed ATP hydrolysis activity after 18 to 24 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 59nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 68nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 77nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 84nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 100nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 110nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 110nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 120nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair
Affinity DataIC50: 133nMAssay Description:Inhibition of Staphylococcus aureus DNA gyrase B expressed in Escherichia coli BL21(DE3) cells assessed ATP hydrolysis activity after 18 to 24 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 147nMAssay Description:Inhibition of Staphylococcus aureus DNA gyrase B expressed in Escherichia coli BL21(DE3) cells assessed ATP hydrolysis activity after 18 to 24 hrs by...More data for this Ligand-Target Pair
Affinity DataIC50: 160nMAssay Description:Inhibition of Staphylococcus aureus NAD(+)-dependent DNA ligaseMore data for this Ligand-Target Pair